Skip to main content
NCBI home page
Gut logoLink to Gut
. 2004 May;53(Suppl 4):iv28–iv34. doi: 10.1136/gut.2003.034298

Assessment of reflux symptom severity: methodological options and their attributes

P Bytzer
PMCID: PMC1867778  PMID: 15082611

Full Text

The Full Text of this article is available as a PDF (174.3 KB).

Figure 1 .

Figure 1

Open in a new tab

Heartburn frequency and severity improves in parallel during medical therapy. Proportion of patients reporting a change in heartburn severity score of 3 (from severe to none) or 2 (from severe to mild or from moderate to none) according to the change in the number of days with heartburn (−7, from daily to none; −6, from daily to one day per week or from six days per week to none, etc). Results are pooled data from three controlled trials comparing esomeprazole with omeprazole (n = 2629) (AstraZeneca, data on file).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bate C. M., Griffin S. M., Keeling P. W., Axon A. T., Dronfield M. W., Chapman R. W., O'Donoghue D., Calam J., Crowe J., Mountfords R. A. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther. 1996 Aug;10(4):547–555. doi: 10.1046/j.1365-2036.1996.44186000.x. [DOI] [PubMed] [Google Scholar]
  2. Bate C. M., Riley S. A., Chapman R. W., Durnin A. T., Taylor M. D. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999 Jan;13(1):59–66. doi: 10.1046/j.1365-2036.1999.00429.x. [DOI] [PubMed] [Google Scholar]
  3. Brun J., Sörngård H. High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care. Fam Pract. 2000 Oct;17(5):401–404. doi: 10.1093/fampra/17.5.401. [DOI] [PubMed] [Google Scholar]
  4. Carlsson R., Dent J., Bolling-Sternevald E., Johnsson F., Junghard O., Lauritsen K., Riley S., Lundell L. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998 Oct;33(10):1023–1029. doi: 10.1080/003655298750026697. [DOI] [PubMed] [Google Scholar]
  5. Carlsson R., Dent J., Watts R., Riley S., Sheikh R., Hatlebakk J., Haug K., de Groot G., van Oudvorst A., Dalväg A. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol. 1998 Feb;10(2):119–124. [PubMed] [Google Scholar]
  6. Castell Donald O., Kahrilas Peter J., Richter Joel E., Vakil Nimish B., Johnson David A., Zuckerman Seth, Skammer Wendy, Levine Jeffrey G. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol. 2002 Mar;97(3):575–583. doi: 10.1111/j.1572-0241.2002.05532.x. [DOI] [PubMed] [Google Scholar]
  7. Elm M., Hellke P., Andrén K., Dahl G., Nyth A. L. Time to relief of episodic symptoms of gastro-oesophageal reflux disease. A crossover comparison of single doses of the effervescent and standard formulations of ranitidine. Scand J Gastroenterol. 1998 Sep;33(9):900–904. doi: 10.1080/003655298750026886. [DOI] [PubMed] [Google Scholar]
  8. Faaij R. A., Van Gerven J. M., Jolivet-Landreau I., Masclee A. A., Vendrig E. M., Schoemaker R. C., Jacobs L. D., Cohen A. F. Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn. Aliment Pharmacol Ther. 1999 Dec;13(12):1605–1610. doi: 10.1046/j.1365-2036.1999.00654.x. [DOI] [PubMed] [Google Scholar]
  9. Fass R., Ofman J. J., Gralnek I. M., Johnson C., Camargo E., Sampliner R. E., Fennerty M. B. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med. 1999 Oct 11;159(18):2161–2168. doi: 10.1001/archinte.159.18.2161. [DOI] [PubMed] [Google Scholar]
  10. Galmiche J. P., Barthelemy P., Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther. 1997 Aug;11(4):765–773. doi: 10.1046/j.1365-2036.1997.00185.x. [DOI] [PubMed] [Google Scholar]
  11. Galmiche J. P., Shi G., Simon B., Casset-Semanza F., Slama A. On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo. Aliment Pharmacol Ther. 1998 Sep;12(9):909–917. doi: 10.1046/j.1365-2036.1998.00384.x. [DOI] [PubMed] [Google Scholar]
  12. Guyatt G. H., Berman L. B., Townsend M., Taylor D. W. Should study subjects see their previous responses? J Chronic Dis. 1985;38(12):1003–1007. doi: 10.1016/0021-9681(85)90098-0. [DOI] [PubMed] [Google Scholar]
  13. Hatlebakk J. G., Hyggen A., Madsen P. H., Walle P. O., Schulz T., Mowinckel P., Bernklev T., Berstad A. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ. 1999 Aug 28;319(7209):550–553. doi: 10.1136/bmj.319.7209.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Havelund T., Aalykke C. The efficacy of a pectin-based raft-forming anti-reflux agent in endoscopy-negative reflux disease. Scand J Gastroenterol. 1997 Aug;32(8):773–777. doi: 10.3109/00365529708996533. [DOI] [PubMed] [Google Scholar]
  15. Holtmann G., Bytzer P., Metz M., Loeffler V., Blum A. L. A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002 Mar;16(3):479–485. doi: 10.1046/j.1365-2036.2002.01207.x. [DOI] [PubMed] [Google Scholar]
  16. Hungin A. P., Rubin G., O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract. 1999 Jun;49(443):463–464. [PMC free article] [PubMed] [Google Scholar]
  17. Joelsson B., Johnsson F. Heartburn--the acid test. Gut. 1989 Nov;30(11):1523–1525. doi: 10.1136/gut.30.11.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Johnson D. A., Benjamin S. B., Vakil N. B., Goldstein J. L., Lamet M., Whipple J., Damico D., Hamelin B. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety. Am J Gastroenterol. 2001 Jan;96(1):27–34. doi: 10.1111/j.1572-0241.2001.03443.x. [DOI] [PubMed] [Google Scholar]
  19. Johnsson F., Moum B., Vilien M., Grove O., Simren M., Thoring M. On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. Scand J Gastroenterol. 2002 Jun;37(6):642–647. doi: 10.1080/00365520212499. [DOI] [PubMed] [Google Scholar]
  20. Johnsson F., Weywadt L., Solhaug J. H., Hernqvist H., Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1998 Jan;33(1):15–20. doi: 10.1080/00365529850166149. [DOI] [PubMed] [Google Scholar]
  21. Junghard O., Carlsson R., Lind T. Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials. Scand J Gastroenterol. 2003 Dec;38(12):1197–1199. doi: 10.1080/00365520310004920. [DOI] [PubMed] [Google Scholar]
  22. Kahrilas P. J., Falk G. W., Johnson D. A., Schmitt C., Collins D. W., Whipple J., D'Amico D., Hamelin B., Joelsson B. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther. 2000 Oct;14(10):1249–1258. doi: 10.1046/j.1365-2036.2000.00856.x. [DOI] [PubMed] [Google Scholar]
  23. Lind T., Havelund T., Carlsson R., Anker-Hansen O., Glise H., Hernqvist H., Junghard O., Lauritsen K., Lundell L., Pedersen S. A. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997 Oct;32(10):974–979. doi: 10.3109/00365529709011212. [DOI] [PubMed] [Google Scholar]
  24. Lind T., Havelund T., Lundell L., Glise H., Lauritsen K., Pedersen S. A., Anker-Hansen O., Stubberöd A., Eriksson G., Carlsson R. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial. Aliment Pharmacol Ther. 1999 Jul;13(7):907–914. doi: 10.1046/j.1365-2036.1999.00564.x. [DOI] [PubMed] [Google Scholar]
  25. MacKenzie C. R., Charlson M. E. Standards for the use of ordinal scales in clinical trials. Br Med J (Clin Res Ed) 1986 Jan 4;292(6512):40–43. doi: 10.1136/bmj.292.6512.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Miner Philip, Jr, Orr William, Filippone Joseph, Jokubaitis Leonard, Sloan Sheldon. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol. 2002 Jun;97(6):1332–1339. doi: 10.1111/j.1572-0241.2002.05769.x. [DOI] [PubMed] [Google Scholar]
  27. Nyrén O., Adami H. O., Bates S., Bergström R., Gustavsson S., Löf L., Sjödén P. O. Self-rating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. J Clin Gastroenterol. 1987 Aug;9(4):408–414. [PubMed] [Google Scholar]
  28. Oliveria S. A., Christos P. J., Talley N. J., Dannenberg A. J. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med. 1999 Jul 26;159(14):1592–1598. doi: 10.1001/archinte.159.14.1592. [DOI] [PubMed] [Google Scholar]
  29. Revicki D. A., Crawley J. A., Zodet M. W., Levine D. S., Joelsson B. O. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999 Dec;13(12):1621–1630. doi: 10.1046/j.1365-2036.1999.00669.x. [DOI] [PubMed] [Google Scholar]
  30. Richter J. E., Campbell D. R., Kahrilas P. J., Huang B., Fludas C. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease. Arch Intern Med. 2000 Jun 26;160(12):1803–1809. doi: 10.1001/archinte.160.12.1803. [DOI] [PubMed] [Google Scholar]
  31. Richter J. E., Kahrilas P. J., Johanson J., Maton P., Breiter J. R., Hwang C., Marino V., Hamelin B., Levine J. G., Esomeprazole Study Investigators Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol. 2001 Mar;96(3):656–665. doi: 10.1111/j.1572-0241.2001.3600_b.x. [DOI] [PubMed] [Google Scholar]
  32. Richter J. E., Kovacs T. O., Greski-Rose P. A., Huang section sign B., Fisher R. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther. 1999 Jun;13(6):795–804. doi: 10.1046/j.1365-2036.1999.00558.x. [DOI] [PubMed] [Google Scholar]
  33. Richter J. E., Peura D., Benjamin S. B., Joelsson B., Whipple J. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. Arch Intern Med. 2000 Jun 26;160(12):1810–1816. doi: 10.1001/archinte.160.12.1810. [DOI] [PubMed] [Google Scholar]
  34. Robinson M., Fitzgerald S., Hegedus R., Murthy A., Jokubaitis L., FAST Trial Investigators Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther. 2002 Mar;16(3):445–454. doi: 10.1046/j.1365-2036.2002.01181.x. [DOI] [PubMed] [Google Scholar]
  35. Sandmark S., Carlsson R., Fausa O., Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol. 1988 Jun;23(5):625–632. doi: 10.3109/00365528809093923. [DOI] [PubMed] [Google Scholar]
  36. Schindlbeck N. E., Klauser A. G., Berghammer G., Londong W., Müller-Lissner S. A. Three year follow up of patients with gastrooesophageal reflux disease. Gut. 1992 Aug;33(8):1016–1019. doi: 10.1136/gut.33.8.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schwizer W., Thumshirn M., Dent J., Guldenschuh I., Menne D., Cathomas G., Fried M. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet. 2001 Jun 2;357(9270):1738–1742. doi: 10.1016/S0140-6736(00)04894-7. [DOI] [PubMed] [Google Scholar]
  38. Talley N. J., Lauritsen K., Tunturi-Hihnala H., Lind T., Moum B., Bang C., Schulz T., Omland T. M., Delle M., Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther. 2001 Mar;15(3):347–354. doi: 10.1046/j.1365-2036.2001.00943.x. [DOI] [PubMed] [Google Scholar]
  39. Veldhuyzen van Zanten S. J., Tytgat K. M., Pollak P. T., Goldie J., Goodacre R. L., Riddell R. H., Hunt R. H. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol. 1993 Mar;46(3):273–279. doi: 10.1016/0895-4356(93)90075-c. [DOI] [PubMed] [Google Scholar]
  40. Venables T. L., Newland R. D., Patel A. C., Hole J., Copeman M. B., Turbitt M. L. Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol. 1997 Jul;32(7):627–632. doi: 10.3109/00365529708996509. [DOI] [PubMed] [Google Scholar]
  41. Venables T. L., Newland R. D., Patel A. C., Hole J., Wilcock C., Turbitt M. L. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol. 1997 Oct;32(10):965–973. doi: 10.3109/00365529709011211. [DOI] [PubMed] [Google Scholar]
  42. Vigneri S., Termini R., Leandro G., Badalamenti S., Pantalena M., Savarino V., Di Mario F., Battaglia G., Mela G. S., Pilotto A. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med. 1995 Oct 26;333(17):1106–1110. doi: 10.1056/NEJM199510263331703. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES